Evidence map›Paper›PMID 36340958›Full record

ArticleGalen medical journal2022

Effects of Dimethyl Fumarate on the Karnofsky Performance Status and Serum S100β Level in Newly Glioblastoma Patients: A Randomized, Phase-II, Placebo, Triple Blinded, Controlled Trial: Effect of DMF On the Serum S100β Level and KPS Score of GBM Patients.

Shafizadeh Milad, Jangholi Ehsan, Maroufi Seyed Farzad, Rostami Mohsen, Bereimipour Ahmad, Majidi Shahram, Mohebi Niayesh, Khoshnevisan Alireza

Open access · diamondAbstract read
In one paragraph

Article in Galen medical journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.2field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Shafizadeh MiladDepartment of Neurosurgery, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Jangholi EhsanDepartment of Neurosurgery, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Maroufi Seyed FarzadFaculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Rostami MohsenSpine Center of Excellence, Yas hospital, Tehran University of Medical Sciences, Tehran, Iran.
Bereimipour AhmadDepartment of Stem Cells and Developmental Biology at Cell Science Research Centre, Royan Institute, Tehran, Iran.
Majidi ShahramDepartment of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, USA.
Mohebi NiayeshDepartment of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, USA.
Khoshnevisan AlirezaDepartment of Neurosurgery, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Tehran University of Medical Sciences · IRShariati Hospital · IRIcahn School of Medicine at Mount Sinai · USRoyan Institute · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Dimethyl FumarateGlioblastomaKanofsky's Performance StatusS100βSurgical Brain Injury

Identifiers

PMID36340958
PMCPMC9616682
OpenAlexW4281704237

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.